Pitch4 slidesComputational triage
01 / 04

Cloudmer + cellico-bio → fragment × fragment search

Cloudmer is our update to Shadow Dogma and Selfish Prion. With cellico-bio it searches a c-mer × c-mer network (FxF = fragment × fragment) for source-grounded review regions across life-course context. State clouds, bridges and absences, golden backbones and unique targets: the Lineage Spatiotemporal Fragment Atlas, on Fragmentum/ProTHub until a native c-mer map exists. Citations & terminology

Cloudmer
our product update of Shadow Dogma + Selfish Prion: c-mer network search with cellico-bio full entry →
FxF
FxF means fragment × fragment (same idea as c-mer × c-mer) full entry →
c-mer
a typed fragment unit in that search space full entry →
Visual abstract

Lineage Spatiotemporal Fragment Atlas

Cloudmer FxF life-course search map: fragment interactions across aging-context nodes

Lineage Spatiotemporal Fragment Atlasgrandmother → mother fetal ovary → future child oocyte → egg + sperm → zygote → embryo → birth → puberty → adult → aging waves → senescence → somatic endpoint. Interactive schematic showing lineage time first, then a fragment-space star chart, then a transparent Cellico Bio review-window overlay. Approved precedent nodes and Cellico Bio computational search nodes are visually distinct.Germ-line continuitySomatic lifetime trajectory / somatic restrictionmaternal mitochondrial protein contextpaternal mitochondrial cargo / clearance contextgestational immune contextCellico Bio fragment review-region search windowgrandmothermother fetal ovaryfuture child oocyteegg + spermzygoteembryobirthpubertyadultaging wavessenescencesomatic endpointTTRIAPPMAPT/tauamyloid contextaging-context nodeATTRwtRNA accessibilityIn silico perturbation delta; validation requiredCellico Bio: fragment review-region search
Approved external precedent

TTR: approved RNAi precedent

TTR is an approved RNAi target-modulation external precedent only. Cellico Bio is not claiming a care program; TTR is an anchored reference node while Cellico Bio maps fragment-level review regions for downstream validation.

refs: dailymed-onpattro-patisiran, dailymed-amvuttra-vutrisiran, fda-rna-based-medicine-patisiran

Cellico Bio computational search

Cellico Bio: fragment review-region search

Computational review region; validation required. The overlay marks where source-grounded fragment review sits across somatic and aging-context layers.

refs: No public citation required for schematic overlay

Comparator context

Aggregation-context comparators

IAPP, MAPT/tau, amyloid context, aging-context nodes, and oldest-old ATTRwt context orient the fragment-space layer. Optional prion-like context stays muted unless citation-gated.

refs: lehallier_2019, oh_2023, ding_2025_text_only, tanskanen_2008_ssa_very_aged, connors_2011_ssa_men, coles_young_2012_supercentenarian_ttr

Comparator context

Oldest-old ATTRwt context

Wild-type transthyretin amyloid is included as a somatic-endpoint context for the oldest old and for male-skewed late-life ATTRwt observations. This is context only, not a Cellico Bio TTR treatment or causality claim.

refs: tanskanen_2008_ssa_very_aged, connors_2011_ssa_men, coles_young_2012_supercentenarian_ttr

Comparator context

RNA accessibility / folding-ensemble context

Exploratory accessibility and folding-ensemble context only. The atlas does not equate RNA accessibility with a protein-state label.

refs: No public citation required for schematic overlay

Cellico Bio layer is computational review-region search only.

Static SVG exportCitation list
Cloudmer interior · fragment × fragment schematic
Schematic 3D fragment-network map with labeled X (c-mer × c-mer), Y (life-course), and Z (state/depth) axes; connected fragment nodes with relative disorder-context clouds; three distinct nested biological-context shells (inherited, tissue, chronological); and glinting review-priority nodes.inheritedtissuechronologicalX · fragment × fragmentY · life-courseZ · state / depth
Cloudmer interior schematic: fragment × fragment (FxF) network projection. Nested inherited / tissue / chronological context shells; review-priority regions glow. Raw scoring, sequences, and candidate identifiers stay private.
02 / 04

Show FCO/FCG across sponsors — without depending on their security stacks.

Main goal: demonstrate Fractal Custody Objects / Graphs through multiple sponsors, independent of each sponsor’s security protocols, while keeping PHI private — and keep this GTM-viable, not custody-only. The Merkle root stays in the user’s vault — like a Bitcoin wallet; sponsors verify without holding it. Worked example: on a bring-your-own-model sponsor, bring an FCO-custodied Pythia model (custody stays FCO/FCG). Antigence + MSM underneath; Cloudmer shortlisting on top — not a claim that aging is solved. Citations & terminology

Cite: Antigence Zenodo · FCO Zenodo · FCG Zenodo · all citations →

Portrait of Byron P. Lee, founder of Cellico Bio
Founder

Byron P. Lee

Founder, Cellico Bio

Main goal: show FCO/FCG through multiple sponsors, independent of each sponsor’s security protocols, while keeping PHI private and remaining GTM-viable — Merkle root in the user’s vault (Bitcoin-wallet style); BYOM sponsor lane for an FCO-custodied Pythia model. Cloudmer (Shadow Dogma + Selfish Prion update) + cellico-bio then search a fragment × fragment (FxF / c-mer × c-mer) network under Antigence + that portable custody model.

Cloudmer fragment × fragment shortlisting across life-course context; computational target shortlisting on Fragmentum/ProTHub substrates.

I’m looking for scientific, translational, sponsor, and company-building partners to pressure-test a GTM-viable FCO/FCG custody path — including BYOM Pythia — with Cloudmer + cellico-bio fragment shortlisting.

03 / 04

Sanity Checks & Acknowledgements

People who reviewed the framing, design, or communication for clarity. Citations & terminology

People who reviewed the framing, design, or communication for clarity.

Portrait of Elliot Roth

Elliot Roth

General Partner, Biopunk Community

Portrait of Jon Beserra

Jon Beserra

Math sanity check

04 / 04

Citations & terminology

Definitions for Cloudmer, FxF, c-mer, FCO/FCG, Merkle root, Pythia, MSM, and Antigence, plus Zenodo / public-repo / industry-standard links. Prefer following a DOI or repo over restating paper claims here.

Terminology

Cloudmer
our product update of Shadow Dogma + Selfish Prion: c-mer network search with cellico-bioThe Shadow Dogma (Zenodo)
FxF
FxF means fragment × fragment (same idea as c-mer × c-mer)
c-mer
a typed fragment unit in that search space
FCO/FCG
Fractal Custody Objects / Graphs: portable hashed custody shown across multiple sponsors, independent of each sponsor’s security protocols; PHI stays private; private Merkle root stays in the user’s vault like a Bitcoin wallet (sponsors verify via public commit, not by holding the root)Fractal Custody Objects — FCO (Zenodo)Fractal Custody Graphs — FCG (Zenodo)
Merkle root
private custody root that stays in the user’s vault like a Bitcoin wallet; sponsors and agents may verify public commits without holding or rewriting the rootFractal Custody Objects — FCO (Zenodo)Fractal Custody Graphs — FCG (Zenodo)
Pythia
FCO-custodied Pythia-family model (Vitalogy→Pythia train template) we can bring into a sponsor lane that supports bring-your-own-model — custody stays FCO/FCG; not the unrelated CLAI prompt-optimizer productFractal Custody Objects — FCO (Zenodo)
MSM
mechanical scientific method: scoring under the Antigence governance backbone + FCO custody so models cannot silently mutate dataAntigence (Zenodo)Fractal Custody Objects — FCO (Zenodo)
Antigence
governance backbone of the cellico.bio framework: AIS-for-AI review / immune-inspired gate (public Zenodo core). Cloudmer shortlisting runs under it — not a Cloudmer product citeAntigence (Zenodo)

Citations & public links

Open a DOI or repo instead of restating paper claims on this deck. Full registry: /cellico/citations.

Claim ceiling: HYPOTHESIS_STAGE_1. Cloudmer star chart, FxF edges, and related pitch figures are schematic until a PUBLIC_OK Cloudmer projection is bound. Computational search and shortlisting only — not medical product or treatment claims. Full research-scope disclaimer.